secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001640334-25-002348
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria raises $3.5M in registered direct offering with warrants
----------------------------------------------------------------

- Issued 2,661,600 shares at $1.315/share, gross proceeds ~$3.5M.
- Concurrent private placement of warrants for 2,661,600 shares at $1.19 exercise price, 5-year term.
- H.C. Wainwright acted as exclusive placement agent; fees 7% cash plus 93,156 placement agent warrants at $1.6438.
- Net proceeds to fund R&D, working capital, and general corporate purposes.
- Offering closed on December 16, 2025; shares registered under Form S-3, warrants unregistered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425002348/0001640334-25-002348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425002348/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-002348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer